MKM Partners Sticks to Its Buy Rating for Curaleaf Holdings (CURLF)
In a report released today, Michael Darda from MKM Partners maintained a Buy rating on Curaleaf Holdings (CURLF). The company’s shares closed last Thursday at $11.94, close to its 52-week high of $12.52.
Curaleaf Holdings has an analyst consensus of Strong Buy, with a price target consensus of $15.02, a 25.2% upside from current levels. In a report issued on December 3, Craig-Hallum also initiated coverage with a Buy rating on the stock with a C$19.00 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $12.52 and a one-year low of $2.54. Currently, Curaleaf Holdings has an average volume of 976.3K.
Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CURLF in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.